Eric Greenwald focuses his practice on US patent prosecution and counseling in the biotechnology space. He has extensive knowledge in the areas of therapeutic antibodies, fusion proteins and small-molecule drugs.
Prior to joining Wolf Greenfield, Eric was an associate at Axinn, Veltrop & Harkrider LLP. There, he represented clients in patent litigation, USPTO proceedings, copyright litigation, and food and drug law. Among other responsibilities, he drafted motions, briefs, pleadings and expert declarations in district court litigations, inter partes reviews (IPRs) and interferences.
In addition, Eric previously worked as an associate at Kenyon & Kenyon LLP representing clients in IP litigation and prosecution in the pharmaceutical and image processing fields. He drafted pleadings, discovery responses, opinions of invalidity and non-infringement, and USPTO office action responses.
Eric has a Certificate in Business Economics and Public Policy from the Wharton School at the University of Pennsylvania.
Ghosh, S., Greenwald, EP., (2018) Expert Q&A on Key Updates in BPCIA Litigation. Thomson Reuters Practice Law: Practice Law the Journal – Litigation. W-015-9057.